About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-ASB4-shRNA
Cat No: shAAV-201532
Availability: 6-8 weeks
AAV-h-ASB5-shRNA
Cat No: shAAV-201533
Availability: 6-8 weeks
AAV-h-ASB6-shRNA
Cat No: shAAV-201534
Availability: 6-8 weeks
AAV-h-ASB7-shRNA
Cat No: shAAV-201535
Availability: 4-5 weeks
AAV-h-ASB8-shRNA
Cat No: shAAV-201536
Availability: 4-5 weeks
AAV-h-ASB9-shRNA
Cat No: shAAV-201538
Availability: 6-8 weeks
AAV-h-ASCC1-shRNA
Cat No: shAAV-201539
Availability: 4-5 weeks
AAV-h-ASCC2-shRNA
Cat No: shAAV-201540
Availability: 4-5 weeks
AAV-h-ASCC3-shRNA
Cat No: shAAV-201541
Availability: 4-5 weeks
AAV-h-ASCL2-shRNA
Cat No: shAAV-201542
Availability: 6-8 weeks
AAV-h-ASCL3-shRNA
Cat No: shAAV-201546
Availability: 6-8 weeks
AAV-h-ASCL4-shRNA
Cat No: shAAV-201547
Availability: 6-8 weeks
